Insider 10b5-1 Sales: 20,000 RSUs Disposed

RSKD filing reports insider dispositions of Common Stock by Aglika Dotcheva under 10b5-1 plans.

Rhea-AI Filing Summary

RSKD filing reports insider dispositions of Common Stock by Aglika Dotcheva under 10b5-1 plans. The filing lists Restricted Stock Units of 20,000 shares dated 07/01/2023 and shows sales of 19,600 shares on 06/01/2026 for $98,039.20 and 400 shares on 05/19/2026 for $2,000.00. The transactions are identified as 10b5-1 Sales.

Insights

Equity Markets Analyst

Transactions are routine insider dispositions executed under pre-arranged plans.

The excerpt shows two 10b5-1 sales by Aglika Dotcheva totaling 20,000 shares sold across two dates: 05/19/2026 and 06/01/2026

These entries are procedural disclosures of sales; cash‑flow treatment beyond the per‑trade proceeds is not shown in the provided excerpt.

Key Figures

RSUs listed: 20,000 shares Sale on 06/01/2026: 19,600 shares Sale on 05/19/2026: 400 shares +2 more

5 metrics

RSUs listed 20,000 shares Restricted Stock Units dated <date>07/01/2023</date>

Sale on 06/01/2026 19,600 shares 10b5-1 Sale for <money>$98,039.20</money>

Sale on 05/19/2026 400 shares 10b5-1 Sale for <money>$2,000.00</money>

Form type Form 144 Notice of proposed sale by a person subject to SEC rules

Per-share proceeds (implied) $5.00/share Derived from 400 shares for $2,000.00 on <date>05/19/2026</date>

Key Terms

10b5-1 Sales, Restricted Stock Units, Form 144

3 terms

10b5-1 Sales regulatory

"10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 20000 | 07/01/2023"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the RSKD Form 144 disclose about Aglika Dotcheva's transactions?

The Form 144 discloses two 10b5-1 sales by Aglika Dotcheva totaling 20,000 shares. The filing shows 19,600 shares sold on 06/01/2026 for $98,039.20 and 400 shares sold on 05/19/2026 for $2,000.00.

Were the sold securities restricted or unrestricted in the RSKD filing?

The filing lists the securities as Restricted Stock Units dated 07/01/2023 and records subsequent sales. The entry labels the original securities as restricted and shows the resulting dispositions under 10b5-1 sales.

How many shares were listed as available to be sold in the filing for RSKD?

The filing shows 20,000 shares associated with the securities to be sold. That 20,000 figure appears next to the Restricted Stock Units dated 07/01/2023 in the provided excerpt.

What proceeds are shown for the transactions in the RSKD excerpt?

Proceeds shown in the excerpt are $98,039.20 for the 19,600-share sale on 06/01/2026 and $2,000.00 for the 400-share sale on 05/19/2026. No aggregate proceeds or company receipt details are provided.

Do these entries state whether sales were pre-arranged or discretionary for RSKD?

Yes. Each sale is labeled as a 10b5-1 Sale, indicating the trades were executed under a pre-arranged trading plan as identified in the excerpt. The filing text does not supply plan start dates or additional plan terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001955807
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Riskified Ltd.
SEC File Number	001-40692
Address of Issuer	220 5th Avenue, 2nd Floor New York NEW YORK 10001
Phone	2033009264
Name of Person for Whose Account the Securities are To Be Sold	AGLIKA DOTCHEVA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	100800.00	93613888	07/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2023	Restricted Stock Units	Issuer			20000	07/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	06/01/2026	19600	98039.20
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	05/19/2026	400	2000.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 7/1/2023 through 7/1/2024.
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Aglika Dotcheva
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)